Relation between ΔNp73, TAp73, and clinicopathological characteristics in 33 patients with prostate carcinoma
| ΔNp73 expression | p Value | TAp73 expression | p Value | |||
|---|---|---|---|---|---|---|
| Positive | Negative | Positive | Negative | |||
| PSA, prostate specific antigen. | ||||||
| Age at diagnosis | ||||||
| <65 | 11 | 7 | 0.717 | 13 | 5 | 1 |
| ⩾65 | 9 | 6 | 11 | 4 | ||
| TNM | ||||||
| T1a–T2b | 8 | 8 | 0.296 | 10 | 6 | 0.259 |
| T3a–T3b | 12 | 5 | 14 | 3 | ||
| Gleason score | ||||||
| 2–6 | 6 | 9 | 0.037 | 9 | 6 | 0.239 |
| 7–10 | 14 | 4 | 15 | 3 | ||
| PSA (ng/ml) | ||||||
| <10.0 | 5 | 4 | 1 | 8 | 1 | 0.384 |
| ⩾10.0 | 15 | 9 | 16 | 8 | ||